Nowadays, CAR-T cell therapy has completely changed the treatment of certain types of cancer. The longer these CAR-T cells survive in the patient’s body, the more effective their response to cancer becomes.   Recently, a research report titled “FOXO1 is a master regulator of memory programming in CAR T cells” was published in the journal Nature. Scientists from institutions such as Stanford University School of Medicine found through their research…